B-intervention	0	4	High
I-intervention	4	5	-
I-intervention	5	14	Intensity
I-intervention	15	23	Interval
I-intervention	24	32	Training
O	33	35	Is
O	36	44	Feasible
O	45	47	in
O	48	53	Women
O	54	56	at
O	57	61	High
O	62	66	Risk
O	67	70	for
O	71	77	Breast
O	78	84	Cancer
O	84	85	.

O	86	90	This
O	91	96	trial
O	97	102	aimed
O	103	105	to
O	106	117	demonstrate
O	118	121	the
O	122	133	feasibility
O	134	136	of
O	137	141	high
O	141	142	-
O	142	151	intensity
O	152	160	interval
O	161	169	training
O	170	171	(
O	171	175	HIIT
O	175	176	)
O	177	179	in
B-eligibility	180	194	postmenopausal
I-eligibility	194	195	,
I-eligibility	196	206	overweight
I-eligibility	206	207	/
I-eligibility	207	212	obese
I-eligibility	213	218	women
I-eligibility	219	221	at
I-eligibility	222	226	high
I-eligibility	227	231	risk
I-eligibility	232	234	of
I-eligibility	235	243	invasive
I-eligibility	244	250	breast
I-eligibility	251	257	cancer
O	258	261	and
O	262	264	to
O	265	272	explore
O	273	277	HIIT
O	278	280	on
O	281	288	changes
O	289	291	in
O	292	309	cardiorespiratory
O	310	317	fitness
O	318	319	(
O	319	322	CRF
O	322	323	)
O	323	324	,
O	325	329	body
O	330	336	weight
O	336	337	,
O	338	341	and
O	342	346	body
O	347	351	mass
O	352	357	index
O	358	359	(
O	359	362	BMI
O	362	363	)
O	364	372	compared
O	373	377	with
O	378	386	moderate
O	386	387	-
O	387	396	intensity
O	397	407	continuous
O	408	416	training
O	417	418	(
O	418	422	MICT
O	422	423	)
O	424	427	and
B-control	428	433	usual
I-control	434	438	care
I-control	439	440	(
I-control	440	442	UC
I-control	442	443	)
O	443	444	.

B-total-participants	445	450	Forty
I-total-participants	450	451	-
I-total-participants	451	455	four
O	456	461	women
O	462	466	were
O	467	477	randomized
O	478	480	to
O	481	485	HIIT
O	485	486	,
O	487	491	MICT
O	491	492	,
O	493	495	or
O	496	498	UC
O	499	502	for
O	503	504	a
O	505	507	12
O	507	508	-
O	508	510	wk
O	510	511	,
O	512	518	thrice
O	519	525	weekly
O	525	526	,
O	527	537	supervised
O	538	546	exercise
O	547	559	intervention
O	559	560	.

O	561	565	HIIT
O	566	574	included
O	575	576	a
O	577	578	5
O	578	579	-
O	579	582	min
O	583	587	warm
O	587	588	-
O	588	590	up
O	591	593	at
O	594	596	50
O	596	597	%
O	597	598	-
O	598	600	70
O	600	601	%
O	602	608	HRpeak
O	608	609	,
O	610	614	four
O	615	621	cycles
O	622	624	of
O	625	626	4
O	627	630	min
O	631	633	at
O	634	636	90
O	636	637	%
O	637	638	-
O	638	641	100
O	641	642	%
O	643	649	HRpeak
O	649	650	,
O	651	659	followed
O	660	662	by
O	663	664	3
O	665	668	min
O	669	671	at
O	672	674	50
O	674	675	%
O	675	676	-
O	676	678	70
O	678	679	%
O	680	686	HRpeak
O	686	687	.

O	688	692	MICT
O	693	702	consisted
O	703	705	of
O	706	708	41
O	709	712	min
O	713	715	at
O	716	718	60
O	718	719	%
O	719	720	-
O	720	722	70
O	722	723	%
O	724	730	HRpeak
O	730	731	.

O	732	743	Feasibility
O	744	747	was
O	748	756	assessed
O	757	759	by
O	760	767	consent
O	767	768	,
O	769	778	adherence
O	778	779	,
O	780	790	compliance
O	790	791	,
O	792	795	and
O	796	805	retention
O	806	811	rates
O	811	812	.

O	813	816	CRF
O	816	817	,
O	818	822	body
O	823	829	weight
O	829	830	,
O	831	834	and
O	835	838	BMI
O	839	843	were
O	844	852	measured
O	853	855	at
O	856	864	baseline
O	865	868	and
O	869	872	end
O	873	875	of
O	876	881	study
O	881	882	.

O	883	891	Repeated
O	891	892	-
O	892	900	measures
O	901	907	linear
O	908	913	mixed
O	914	920	models
O	921	925	were
O	926	930	used
O	931	933	to
O	934	940	assess
O	941	947	within
O	947	948	-
O	949	952	and
O	953	960	between
O	960	961	-
O	961	966	group
O	967	978	differences
O	978	979	.

O	980	987	Average
O	988	991	age
O	992	995	was
B-age	996	998	63
I-age	998	999	.
I-age	999	1000	9
I-age	1001	1002	±
I-age	1003	1004	8
I-age	1004	1005	.
I-age	1005	1006	8
I-age	1007	1009	yr
I-age	1009	1010	.

O	1011	1014	BMI
O	1015	1018	was
O	1019	1021	30
O	1021	1022	.
O	1022	1023	9
O	1024	1025	±
O	1026	1027	5
O	1027	1028	.
O	1028	1029	7
O	1030	1032	kg
O	1032	1033	·
O	1033	1034	m
O	1034	1035	.

O	1036	1048	Participants
O	1049	1058	completed
O	1059	1061	90
O	1061	1062	%
O	1063	1066	and
O	1067	1069	89
O	1069	1070	%
O	1071	1073	of
O	1074	1078	HIIT
O	1079	1082	and
O	1083	1087	MICT
O	1088	1096	workouts
O	1096	1097	,
O	1098	1110	respectively
O	1110	1111	,
O	1112	1116	with
O	1117	1120	100
O	1120	1121	%
B-outcome	1122	1132	compliance
O	1133	1135	to
O	1136	1139	the
O	1140	1148	exercise
O	1149	1162	prescriptions
O	1162	1163	.

B-outcome	1164	1166	No
I-outcome	1167	1174	serious
I-outcome	1175	1182	adverse
I-outcome	1183	1189	events
O	1190	1194	were
O	1195	1203	reported
O	1203	1204	.

O	1205	1213	Compared
O	1214	1218	with
O	1219	1223	MICT
O	1224	1227	and
O	1228	1230	UC
O	1230	1231	,
O	1232	1236	HIIT
O	1237	1246	exhibited
O	1247	1259	improvements
O	1260	1262	in
B-outcome	1263	1269	change
I-outcome	1270	1272	in
I-outcome	1273	1282	treadmill
I-outcome	1283	1287	time
O	1288	1289	(
B-iv-cont-mean	1289	1292	101
I-iv-cont-mean	1293	1294	s
O	1295	1302	greater
O	1303	1307	than
O	1308	1312	MICT
O	1312	1313	,
O	1314	1317	and
B-cv-cont-mean	1318	1321	125
I-cv-cont-mean	1322	1323	s
O	1324	1331	greater
O	1332	1336	than
O	1337	1339	UC
O	1339	1340	,
O	1341	1353	respectively
O	1353	1354	,
O	1355	1356	P
O	1357	1358	<
O	1359	1360	0
O	1360	1361	.
O	1361	1364	001
O	1364	1365	)
O	1365	1366	.

O	1367	1375	Compared
O	1376	1380	with
O	1381	1383	UC
O	1383	1384	,
O	1385	1389	HIIT
O	1390	1399	exhibited
O	1400	1411	improvement
O	1412	1414	in
B-outcome	1415	1422	changes
I-outcome	1423	1425	in
I-outcome	1426	1434	absolute
I-outcome	1435	1438	and
I-outcome	1439	1447	relative
I-outcome	1448	1449	V
I-outcome	1449	1450	˙
I-outcome	1450	1456	O2peak
O	1457	1458	(
O	1458	1459	a
B-iv-cont-mean	1460	1461	0
I-iv-cont-mean	1461	1462	.
I-iv-cont-mean	1462	1464	15
I-iv-cont-mean	1464	1465	-
I-iv-cont-mean	1465	1466	L
I-iv-cont-mean	1466	1467	·
I-iv-cont-mean	1467	1470	min
O	1471	1479	increase
O	1479	1480	,
O	1481	1482	P
O	1483	1484	=
O	1485	1486	0
O	1486	1487	.
O	1487	1490	005
O	1490	1491	,
O	1492	1495	and
O	1496	1497	a
B-cv-cont-mean	1498	1499	2
I-cv-cont-mean	1499	1500	.
I-cv-cont-mean	1500	1501	3
I-cv-cont-mean	1501	1502	-
I-cv-cont-mean	1502	1504	mL
I-cv-cont-mean	1504	1505	·
I-cv-cont-mean	1505	1507	kg
I-cv-cont-mean	1507	1508	⋅
I-cv-cont-mean	1508	1511	min
O	1512	1520	increase
O	1520	1521	,
O	1522	1523	P
O	1524	1525	=
O	1526	1527	0
O	1527	1528	.
O	1528	1531	004
O	1531	1532	)
O	1532	1533	.

O	1534	1539	There
O	1540	1544	were
O	1545	1547	no
O	1548	1559	significant
O	1560	1571	differences
O	1572	1579	between
O	1580	1586	groups
O	1587	1590	for
B-outcome	1591	1595	body
I-outcome	1596	1602	weight
I-outcome	1603	1605	or
I-outcome	1606	1609	BMI
O	1610	1611	(
O	1611	1612	P
O	1613	1614	>
O	1615	1616	0
O	1616	1617	.
O	1617	1619	05
O	1619	1620	)
O	1620	1621	.

O	1622	1626	HIIT
O	1627	1629	is
O	1630	1638	feasible
O	1638	1639	,
O	1640	1644	safe
O	1644	1645	,
O	1646	1649	and
O	1650	1655	seems
O	1656	1658	to
O	1659	1666	promote
O	1667	1674	greater
O	1675	1687	improvements
O	1688	1690	in
O	1691	1694	CRF
O	1695	1703	compared
O	1704	1708	with
O	1709	1713	MICT
O	1714	1717	and
O	1718	1720	UC
O	1721	1723	in
O	1724	1729	women
O	1730	1732	at
O	1733	1737	high
O	1738	1742	risk
O	1743	1746	for
O	1747	1753	breast
O	1754	1760	cancer
O	1760	1761	.
